Genetic and biochemical analysis of cdc-14
cdc-14 的遗传和生化分析
基本信息
- 批准号:7993147
- 负责人:
- 金额:$ 7.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-20 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAnimal ModelBe++ elementBerylliumBiochemicalBiological ModelsCaenorhabditis elegansCell CycleCell Cycle RegulationCell NucleusCell divisionCellsCuesCyclin-Dependent Kinase InhibitorCytoplasmDefectDevelopmentElementsFamilyFoundationsG1 PhaseGene MutationGene OrderGenesGeneticGenetic EpistasisGenetic ScreeningGoalsGrowth and Development functionHomologous GeneHumanImageryLinkMaintenanceMalignant NeoplasmsMediatingMolecularOrganismPathway interactionsPatternPhasePhosphoric Monoester HydrolasesPlayProcessProductionRelative (related person)ReporterReporter GenesResearchRoleSeriesSignal TransductionSpecific qualifier valueStructureTechniquesTestingTissuesTransgenesTumor Suppressor ProteinsYeastsbasecell typedesigndevelopmental geneticsgenome-widein vivoinsightmRNA Stabilitymembermetaplastic cell transformationnovelphysical propertypositional cloningprecursor cellresearch studytumoryeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Our overall goal is to achieve an understanding of the molecular mechanisms regulating cell divisions. The proposed studies utilize the model organism Caenorhabditis elegans to investigate the regulatory interactions between developmental signals and the cell cycle. Our research plan proposes to identify the pathways that control cdc-14, a critical regulator of cell-cycle entry during development. cdc-14 acts together with cki-1, a member of the p27Kip1 family of cyclin-dependent kinase inhibitors, within a network that regulates cell-cycle quiescence. Our strategies apply the excellent developmental genetics of C. elegans to reveal detailed mechanisms to inhibit G1 progression by modulating cdc-14 activity.
We propose three aims to identify the pathways that connect developmental signals to control of G1 progression: 1) To determine the mechanisms used to restrict cdc-14 activity to those cells in which this phosphatase specifies temporarily cell-cycle quiescence during development. We focus on two processes that direct the cell-type specification of cdc-14 activity: restricted expression and subcellular compartmentalization. These analyses utilize a series of modified cdc-14 transgenes designed to manipulate CDC-14 expression and subcellular localization and the corresponding G1 regulatory activity of such transgenes. 2) To identify additional genes that act within the cdc-14-mediated network in a reverse-genetic screen for defects in control of G1 progression. Our screen utilizes a strategy to produce visible defects in cell- cycle control, allowing for efficient and simple identification. 3) To develop a genetic hierarchy using the genes identified in the described screen. The organization of this network will be based on tests to define the genetic interactions, effect on CDC-14 expression and subcellular localization of the new genes. Together, the proposed studies will define the pathway to control cdc-14 activity during development and will provide insights into the general mechanisms used to integrate cell-cycle regulation with growth and development. The goal of this proposal is to understand the mechanisms used to control the activity of cdc-14, a gene that plays an important role to temporarily stop cells from dividing. These results may provide insights into how tumors are formed since cancers are characterized by defects in genes that control cell divisions.
描述(由申请人提供):我们的总体目标是了解调节细胞分裂的分子机制。拟议的研究利用秀丽隐杆线虫模型的模型来研究发育信号与细胞周期之间的调节相互作用。我们的研究计划建议确定控制CDC-14的途径,CDC-14是开发过程中细胞周期进入的关键调节剂。 CDC-14与CKI-1一起起作用,CKI-1是细胞周期蛋白依赖性激酶抑制剂的P27KIP1家族的成员,在调节细胞周期静止的网络中。我们的策略应用了秀丽隐杆线虫的出色发育遗传学,以揭示通过调节CDC-14活性来抑制G1进展的详细机制。
我们提出的三个旨在确定将发育信号连接到G1进展的途径:1)确定用于将CDC-14活性限制为该磷酸酶指定发育过程中暂时细胞周期静止的细胞的机制。我们专注于指导CDC-14活性的细胞类型规范的两个过程:受限的表达和亚细胞分区化。这些分析利用了一系列改良的CDC-14转基因,旨在操纵CDC-14表达和亚细胞定位以及此类转基因的相应G1调节活性。 2)在反遗传筛选中确定在CDC-14介导的网络中起作用的其他基因,以控制G1进展的缺陷。我们的屏幕利用策略在细胞周期控制中产生可见的缺陷,从而有效而简单。 3)使用所述筛选中鉴定的基因开发遗传层次结构。该网络的组织将基于测试,以定义遗传相互作用,对CDC-14表达的影响以及新基因的亚细胞定位。拟议的研究将共同定义在开发过程中控制CDC-14活性的途径,并将提供有关将细胞周期调节与生长和发育相结合的一般机制的见解。该提案的目的是了解用于控制CDC-14活性的机制,CDC-14的活性是该基因在暂时阻止细胞分裂的基因。这些结果可能会提供有关如何形成肿瘤的见解,因为癌症的特征是控制细胞分裂的基因中的缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R. MAKO SAITO其他文献
R. MAKO SAITO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R. MAKO SAITO', 18)}}的其他基金
相似海外基金
Role of miR-195 in Chemo-Resistant Ovarian Cancer
miR-195 在化疗耐药性卵巢癌中的作用
- 批准号:
10640540 - 财政年份:2023
- 资助金额:
$ 7.14万 - 项目类别:
A germline- and promoter-independent strategy to gain access to all cell types in the brain
一种独立于种系和启动子的策略,可获取大脑中所有细胞类型
- 批准号:
10651435 - 财政年份:2023
- 资助金额:
$ 7.14万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 7.14万 - 项目类别:
miR-342, a novel glucocorticoid-responsive miRNA necessary for Foxp3+ regulatory T cell function
miR-342,一种新的糖皮质激素反应性 miRNA,是 Foxp3 调节 T 细胞功能所必需的
- 批准号:
10671943 - 财政年份:2023
- 资助金额:
$ 7.14万 - 项目类别: